0001562180-23-004632.txt : 20230531
0001562180-23-004632.hdr.sgml : 20230531
20230531172224
ACCESSION NUMBER: 0001562180-23-004632
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230530
FILED AS OF DATE: 20230531
DATE AS OF CHANGE: 20230531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liu Ye
CENTRAL INDEX KEY: 0001840407
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 23982119
MAIL ADDRESS:
STREET 1: ROOM 502-I, WANT WANT PLAZA
STREET 2: NO. 211 SHIMEN YI ROAD
CITY: SHANGHAI
STATE: F4
ZIP: 200041
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0407
4
2023-05-30
false
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001840407
Liu Ye
56F, ONE MUSEUM PLACE, 669 XIN ZHA ROAD
JING'AN DISTRICT
SHANGHAI
200041
true
false
false
false
false
Common Stock, $0.001 par value
2023-05-30
4
S
false
1.00
6.00
D
3010721.00
I
Ocumension Therapeutics
Sale of one share to test new broker
The shares are held by Ocumension Therapeutics. The reporting person is Chief Executive Officer and a Director of Ocumension Therapeutics. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
/s/ Ron Honig, Attorney-in-Fact
2023-05-31